Advertisement

Cost of Care

Drug Prices and Value: Finding Middle Ground

The advent of targeted therapies along with complex personalized treatment regimens has added many effective tools to the oncology armamentarium. But progress...

Issues in Oncology

Immunotherapy Could Be the Wave of the Future, but Problems and Challenges Cannot Be Ignored

Immunotherapy is on its way. A few agents have already been approved: ipilimumab in 2011 for melanoma; nivolumab in 2015 for non–small cell lung cancer and...

 

Issues in Oncology

ESTRO 2016: Failure to Publish Phase III Radiotherapy Trial Results Exposes Patients to Risks Without Providing Benefits for Others

Although the publication of results of clinical trials carried out in the United States within 12 months of their completion has been mandatory since 2007...


Advertisement

More Top Stories

Lung Cancer

Douglas E. Wood, MD, on Lung Cancer Screening: Status and Patient Selection

Breast Cancer

Breast Cancer Vaccines Moving Forward at a Fast Clip

Vaccines for both secondary and primary prevention of breast cancer are showing potential in clinical trials, according to Elizabeth A. Mittendorf, MD, PhD, who is leading much of the vaccine research at the University of Texas MD Anderson Cancer Center, Houston. Vaccine platforms being explored...

Advertisement

ESTRO 2016: SBRT in Early-Stage Lung Cancer Linked to Increased Risk of Noncancer Deaths

Researchers have found that treating patients who have early-stage non–small cell lung cancer (NSCLC) with stereotactic body radiation therapy (SBRT) is associated with a small but increased risk of death from causes other than cancer, according to findings presented at the European Society...

Breast Cancer

Steven Shak, MD, on Breast Cancer–Specific Mortality

Global Cancer Care

Cancer on the Global Stage: Incidence and Cancer-Related Mortality in Israel

The ASCO Post is pleased to continue this special feature on the worldwide cancer burden. In this issue, we feature a close look at the cancer incidence and mortality rates in Israel. The aim of this special feature is to highlight the global cancer burden for various countries of the world. For...

Diversity Training Key to Increasing Cultural Competence Among Oncology Surgeons

A study in the Journal of Oncology Practice (JOP)1 measured the level of cultural competence among surgeons from six hospitals in the Puget Sound region of Washington State, home to a large population of American Indians and Alaskan Natives. According to the study, “Assessing Cultural Competence...

ESTRO 2016: Radiation and L19-IL2 Immunotherapy Combination Shows Activity in Preclinical Models

Radiation therapy not only targets and destroys cancer cells, but also helps to activate the immune system against their future proliferation. However, this immune response is often not strong enough to be able to completely eradicate tumors, and even when it is, its effect is limited to the area...

Prostate Cancer

Christopher Brian Allard, MD, on Prostate Cancer Risk and Regular Aspirin Use

Highlights From the 2016 Quality Care Symposium and Multidisciplinary Head and Neck Cancer Symposium

Direct your patients to the Cancer.Net Blog, www.cancer.net/blog, to listen to a podcast from the 2016 Quality Care Symposium on research highlighting efforts to make sure patients are getting the most appropriate care while also addressing the costs of cancer care.

Also on the blog, learn more...

Advertisement

ESTRO 2016: Failure to Publish Phase III Radiotherapy Trial Results Exposes Patients to Risks Without Providing Benefits for Others

Although the publication of results of clinical trials carried out in the United States within 12 months of their completion has been mandatory since 2007, a remarkably high number of phase III radiotherapy trials did not do so, according to new research presented at the European Society for...